Chris Leaston

Chris Leaston has a diverse work experience in the field of business development and clinical trials. Chris is currently the Director of Business Development at Anju Software, starting in June 2023. Prior to this, they served as the Director of Decentralized Clinical Trials at Huma from 2021 to 2023. From 2020 to 2021, Chris held the position of Director of Business Development at SDC (Statistics & Data Corporation). Before that, they worked at NAMSA as a Business Development Executive for Clinical, from October 2019 to October 2020, and as an Account Manager in the Southeast region from March 2017 to October 2019. Chris also has experience as a Business Development Manager at PharPoint Research, Inc. and Circassia from 2016 to 2017 and 2015 to 2017 respectively. Additionally, they worked as a Budgets and Proposals Executive at Chiltern from 2013 to 2015. Chris started their career as a Contracts Analyst at Quintiles from 2008 to 2010.

Chris Leaston attended North Carolina State University where they earned a Bachelor of Arts (B.A.) degree in Political Science and Government. Chris completed their studies in 2003.